Vargas Wendy S, Heier Linda A, Rodriguez Fausto, Bergner Amanda, Yohay Kaleb
Division of Pediatric Neurology, Weill Cornell Medical Center/New York Presbyterian Hospital, USA.
Division of Neuroradiology, Weill Cornell Medical Center/New York Presbyterian Hospital, USA.
Neuroimage Clin. 2014 Jan 4;4:258-65. doi: 10.1016/j.nicl.2013.12.010. eCollection 2014.
Whereas T2 hyperintensities known as NF-associated bright spots are well described in patients with neurofibromatosis type I (NF-1), there is a paucity of data on incidental findings in patients with neurofibromatosis type II (NF-2). We aim to characterize unexplained imaging findings in the brains of patients with NF-2.
This study is retrospective, HIPAA-compliant and approved by the institutional review board. 34 patients with NF-2 underwent brain magnetic resonance imaging (MRI) between January 2000 and December 2012. T2 and T1-weighted imaging characteristics, diffusion weighted imaging (DWI) characteristics, and enhancement patterns were analyzed by visual inspection. Clinical information at time of imaging was available for all patients. Neuropathologic data was available for one patient.
We found unexplained T2 hyperintensities present on initial imaging in 23/34 patients (67%). Of the 23 patients with unexplained MRI findings, 15 (65%) had wedge-shaped T2 hyperintensities in the subcortical white matter extending to the cortex suggestive of a cortical dysplasia. 3 additional cases (17%) had a lesion within the cerebellum suggestive of a neuronal migration anomaly. In one patient where the MRI was suggestive of focal cortical dysplasia, histopathologic analysis revealed dysplastic glial foci without other alterations of cortical architecture or other cytologic abnormalities.
Unexplained T2 hyperintensities occur frequently in patients with NF-2. While they may not be the NF-2 equivalent of NF-associated bright spots seen in NF-1, some of these T2 hyperintensities in patients with NF-2 may represent underlying disorders of neuronal migration. Further studies are needed to validate our findings.
虽然1型神经纤维瘤病(NF-1)患者中被称为NF相关亮点的T2高信号已得到充分描述,但关于2型神经纤维瘤病(NF-2)患者偶然发现的数据却很少。我们旨在描述NF-2患者大脑中无法解释的影像学表现。
本研究为回顾性研究,符合健康保险流通与责任法案(HIPAA)要求,并经机构审查委员会批准。2000年1月至2012年12月期间,34例NF-2患者接受了脑磁共振成像(MRI)检查。通过肉眼观察分析T2加权成像、T1加权成像特征、扩散加权成像(DWI)特征及强化模式。所有患者均有成像时的临床信息。有1例患者可获得神经病理学数据。
我们发现23/34例患者(67%)在初次成像时存在无法解释的T2高信号。在这23例有无法解释的MRI表现的患者中,15例(65%)在皮质下白质有楔形T2高信号,延伸至皮质,提示皮质发育异常。另外3例(17%)在小脑内有病变,提示神经元迁移异常。在1例MRI提示局灶性皮质发育异常的患者中,组织病理学分析显示有发育异常的胶质病灶,无皮质结构的其他改变或其他细胞学异常。
无法解释的T2高信号在NF-2患者中频繁出现。虽然它们可能并非NF-1中所见的NF相关亮点在NF-2中的对应表现,但NF-2患者中的一些T2高信号可能代表潜在的神经元迁移障碍。需要进一步研究来验证我们 的发现。